Evidence map›Paper›PMID 39132487›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Multivariate, Multi-omic Analysis in 799,429 Individuals Identifies 134 Loci Associated with Somatoform Traits.

Christal N Davis, Sylvanus Toikumo, Alexander S Hatoum, Yousef Khan, Benjamin K Pham, Shreya R Pakala, Kyra L Feuer, Joel Gelernter, Sandra Sanchez-Roige, Rachel L Kember and 1 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Christal N DavisMental Illness Research, Education, and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.ORCID 0000-0003-3974-5598
Sylvanus ToikumoMental Illness Research, Education, and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.ORCID 0000-0002-6024-0693
Alexander S HatoumDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-8002-7267
Yousef KhanDepartment of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.ORCID 0009-0002-3093-3947
Benjamin K PhamDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Shreya R PakalaDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Kyra L FeuerDepartment of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-3704-6136
Joel GelernterDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-4067-1859
Sandra Sanchez-RoigeDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0001-6137-5699
Rachel L KemberMental Illness Research, Education, and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.ORCID 0000-0001-8820-2659
Henry R KranzlerMental Illness Research, Education, and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.ORCID 0000-0002-1018-0450

Funding

Postdoctoral Training Program in Genomic MedicineT32HG009495 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Katherine L. Nathanson, Bogdan Pasaniuc · 2017 to 2026
$4.2M
Leveraging GWAS Findings to Map Variants and Identify Novel Effector Genes for Alcohol-Related TraitsR01AA030056 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI Struan F A Grant, MATTHEW S KAYSER · 2023 to 2026
$2.5M
Characterizing the phenotypic spectrum associated with genetic liability for alcohol use disorderK01AA028292 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI KEMBER, RACHEL LORRAINE · 2021 to 2024
$505k
Genetic Vulnerability for Sustained Multi-Substance Use in MVPI01BX004820 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI Amy Caroline Justice, HENRY RICHARD KRANZLER · 2020 to 2026
–
BLRD VA I01 BX004820NHGRI NIH HHS T32 HG009495NIAAA NIH HHS K01 AA028292NIAAA NIH HHS R01 AA030056
6 · The paper itself

Abstract

Somatoform traits, which manifest as persistent physical symptoms without a clear medical cause, are prevalent and pose challenges to clinical practice. Understanding the genetic basis of these disorders could improve diagnostic and therapeutic approaches. With publicly available summary statistics, we conducted a multivariate genome-wide association study (GWAS) and multi-omic analysis of four somatoform traits-fatigue, irritable bowel syndrome, pain intensity, and health satisfaction-in 799,429 individuals genetically similar to Europeans. Using genomic structural equation modeling, GWAS identified 134 loci significantly associated with a somatoform common factor, including 44 loci not significant in the input GWAS and 8 novel loci for somatoform traits. Gene-property analyses highlighted an enrichment of genes involved in synaptic transmission and enriched gene expression in 12 brain tissues. Six genes, including members of the CD300 family, had putatively causal effects mediated by protein abundance. There was substantial polygenic overlap (76-83%) between the somatoform and externalizing, internalizing, and general psychopathology factors. Somatoform polygenic scores were associated most strongly with obesity, Type 2 diabetes, tobacco use disorder, and mood/anxiety disorders in independent biobanks. Drug repurposing analyses suggested potential therapeutic targets, including MEK inhibitors. Mendelian randomization indicated potentially protective effects of gut microbiota, including

Identifiers

PMID39132487
PMCPMC11312645

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.